A new hypothesis of pathogenesis based on the divorce between mitochondria and their host cells: Possible relevance for alzheimer's disease

Current Alzheimer Research

Volumn 7, Issue 4, 2010, Pages 307-322

  Agnati, L F ^a   Guidolin, D ^b   Baluka F ^c   Leo, G ^a   Barlow, P W ^d   Carone, C ^a   Genedani, S ^a  

^a IRCCS SAN CAMILLO HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

synuclein; Amyloid precursor protein; Energide concept; Mitochondrial migration; Mitochondrial pathogenic role; Neurodegenerative diseases; Tunneling nanotubes

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; FREE RADICAL; MITOCHONDRIAL DNA; NANOTUBE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE;

ALZHEIMER DISEASE; ARTICLE; CELL MIGRATION; CELL RENEWAL; CENTRAL NERVOUS SYSTEM; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GENE MUTATION; GLIA CELL; GLIOMA CELL; HOST CELL; HUMAN; HYPOTHESIS; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SUBSTANTIA NIGRA;

ALZHEIMER DISEASE; ANIMALS; CELL COMMUNICATION; COCULTURE TECHNIQUES; HUMANS; MITOCHONDRIA; MODELS, NEUROLOGICAL; SYMBIOSIS;

EID: 77953330985     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720510791162395     Document Type: Article

References (106)

1. Mazia D. The chromosome cycle and the centrosome cycle in the mitotic cycle. Int Rev Cytol 100: 49-92 (1987).
2. Harris H. The birth of the cell. Yale University Press, New Haven and London (1999).
3. Baluška F, Volkmann D, Barlow PW. Eukaryotic cells and their Cell Bodies: Cell theory revisited. Ann Bot 94: 9-32 (2004).
4. Mazia D. The cell cycle at the cellular level. Eur J Cell Biol 61 (Suppl 38):14 (1993).
5. Margulis L. Origins of species: acquired genomes and individuality. Biosystems 31(2-3): 121-125 (1993).
6. Agnati LF, Fuxe K, Baluška F, Guidolin D. Implications of the 'Energide' concept for communication and information handling in the central nervous system. J Neural Transm 116: 1037-1052 (2009).
7. Agnati LF, Fuxe K. Volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-type machine. Prog Brain Res 125: 3-19 (2000).
8. Richmond MH, Smith DC. The cell as a habitat. A Royal Society discussion organized by MH Richmond and DC Smith, F.R.S. held on 5 and 6 April 1978. The Royal Society. London (1979).
9. Schapira AH. Mitochondrial disease. Lancet 368: 70-82 (2006).
10. Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E, et al. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci USA 104: 1325-1330 (2007).
11. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 6: 513-519 (2000).
12. Keeling PJ, Palmer JD. Horizontal gene transfer in eukaryotic evolution. Nat Rev Genet 9: 605-618 (2008).
13. Beiko RG, Ragan MA. Detecting lateral genetic transfer: a phylogenetic approach. Methods Mol Biol 452: 457-469 (2008).
14. Timmis JN, Ayliffe MA, Huang CY, Martin W. Endosymbiotic gene transfer: organelle genomes forge eukaryotic chromosomes Nat Rev Genet 5: 123-135 (2004).
15. Turner C, Killoran C, Thomas NS, Rosenberg M, Chuzhanova NA, Johnston J, et al. Human genetic disease caused by de novo mitochondrial-nuclear DNA transfer. Hum Genet 112: 303-309 (2003).
16. Wolf K. Insertion of mitochondrial DNA in the chromosomes - a cause for cancer and aging? Endocytob Cell Res 11: 211-218 (1996).
17. Belting M, Wittrup A. Nanotubes, exosomes, and nucleic acid- binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease. J Cell Biol 183: 1187-1191 (2008).
18. Davis DM, Sowinski S. Membrane nanotubes: dynamic long- distance connections between animal cells. Nat Rev Mol Cell Biol 9: 431-436 (2008).
19. Goncharova LB, Tarakanov AO. Nanotubes at neural and immune synapses. Curr Med Chem 15: 210-218 (2008).
20. Gurke S, Barroso JF, Gerdes HH. The art of cellular communication: tunneling nanotubes bridge the divide. Histochem Cell Biol 129: 539-550 (2008).
21. Gerdes HH, Carvalho RN. Intercellular transfer mediated by tunneling nanotubes. Curr Opin Cell Biol 20: 470-475 (2008).
22. Sherer NM, Mothes W. Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis. Trends Cell Biol 18: 414-420 (2008).
23. Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH. Nanotubular highways for intercellular organelle transport. Science 303: 1007-1010 (2004).
24. Gerdes HH, Bukoreshtliev NV, Barroso JF. Tunneling nanotubes: a new route for the exchange of components between animal cells. FEBS Lett 581: 2194-2201 (2007).
25. Baluška F, Volkmann D, Barlow PW. Cell-cell channels and their implications for Cell Theory. In: 'Cell-Cell Channels'. (Ed: Baluška F, Volkmann D, Barlow PW), Landes Bioscience, Georgetown TX/Springer Science, New York, pp. 1-18 (2006).
26. Chinnery HR, Pearlman E, McMenamin PG. Membrane nanotubes in vivo: a feature of MHC class II+ cells in the mouse cornea. J Immunol 180: 5779-5783 (2008).
27. Koyanagi M, Brandes RP, Haendeler J, Zeiher AM, Dimmeler S. Cell- to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes: a novel mechanism for cell fate changes? Circ Res 96: 1039-1041(2005).
28. Csordás A. Mitochondrial transfer between eukaryotic animal cells and its physiologic role. Rejuvenation Res 9: 450-454 (2006).
29. Sowinski S, Jolly C, Berninghausen O, Purbhoo MA, Chauveau A, Köhler K, et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat Cell Biol 10: 211-219 (2008).
30. Onfelt B, Nedvetzki S, Benninger RK, Purbhoo MA, Sowinski S, Hume AN, et al. Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteria. J Immunol 177: 8476-8483 (2006).
31. Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT, et al. Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol 11: 328-336 (2009).
32. Doolittle WF. Phylogenetic classification and the universal tree. Science 284: 2124-2129 (1999).
33. Agnati LF, Barlow PW, Baldelli E, Baluška F. Are maternal mitochondria the selfish entities that are masters of the cells of eukaryotic multicelullar organisms? Commun Integr Biol, In Press (2009).
34. Gabaldón T, Huynen MA. From endosymbiont to host-controlled organelle: the hijacking of mitochondrial protein synthesis and metabolism. PLoS Comput Biol 3: e219 (2007).
35. Wallace DC. Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. Annu Rev Biochem 76: 781-821 (2007).
36. Barlow PW. The hierarchical organization of plants and the transfer of information during their development. Post py Biol Komórk 14: 63-82 (1987).
37. Barlow PW. Living plant systems: how robust are they in the absence of gravity? Adv Space Res 12: 1975-1986 (1999).
38. Zeh JA, Zeh DW. Maternal inheritance, sexual conflict and the maladapted male. Trends Genet 21: 281-286 (2005).
39. Ryan MT, Hoogenraad NJ. Mitochondrial-nuclear commu- nications. Annu Rev Biochem 76: 701-22 (2007).
40. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39: 359-407 (2005).
41. Reddy PH, Beal MF. Amyloid, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14: 45-53 (2008).
42. Tahara EB, Navarete FD, Kowaltowski AJ. Tissue-, substrate-and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic Biol Med 46: 1283-1297 (2009).
43. Kakkar P, Singh BK. Mitochondria: a hub of redox activities and cellular distress control. Mol Cell Biochem 305: 235-253 (2007).
44. Diaz F, Moraes CT. Mitochondrial biogenesis and turnover. Cell Calcium 44: 24-35 (2008).
45. Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462: 245- 253 (2007).
46. Tatsuta T, Langer T. Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J 27: 306-314 (2008).
47. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 25: 1241-1252 (2006).
48. Fujie M, Kuroiwa H, Suzuki T, Kawano S, Kuroiwa H. Organelle DNA synthesis in the quiescent centre of Arabidopsis thaliana. J Exp Bot 44: 689-693 (1993).
49. Seguí-Simarro JM, Coronado MJ, Staehelin LA. The mitochondrial cycle of Arabidopsis shoot apical meristem and leaf primordium meristematic cells is defined by a perinuclear tentaculate/cage-like mitochondrion. Plant Physiol 148: 1380-1393 (2008).
50. Falkenberg M, Larsson NG, Gustafsson CM. DNA replication and transcription in mammalian mitochondria. Ann Rev Biochem 76: 679-699 (2007).
51. Zhang XN, Qi M. Mitochondrion and its related disorders: making a comeback. J Zhejiang Univ Sci B 9: 90-92 (2008).
52. Gregor M, Janovská A, Stefl B, Zurmanová J, Mejsnar J. Substrate channelling in a creatine kinase system of rat skeletal muscle under various pH conditions. Exp Physiol 88: 1-6 (2003).
53. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423 (2004).
54. Zeviani M, Antozzi C. Mitochondrial disorders. Mol Hum Reprod 3: 133-148 (1997).
55. Vila M, Ramonet D, Perier C. Mitochondrial alterations in Parkinson's disease: new clues. J Neurochem 107: 317-28 (2008).
56. Wallace DC. Mitochondrial diseases in man and mouse. Science 283: 1482-1488 (1999).
57. Wallace KB, Eells JT, Madeira VM, Cortopassi G, Jones DP. Mitochondria-mediated cell injury. Symposium overview. Fundam Appl Toxicol 38: 23-37 (1997).
58. Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res 488: 119-133 (2001).
59. Yan LJ, Thangthaeng N, Forster MJ. Changes in dihydrolipoamide dehydrogenase expression and activity during postnatal development and aging in the rat brain. Mech Ageing Dev 129: 282-290 (2008).
60. Murakami T, Nagai M, Miyazaki K, Morimoto N, Ohta Y, Kurata T, et al. Early decrease of mitochondrial DNA repair enzymes in spinal motor neurons of presymptomatic transgenic mice carrying a mutant SOD1 gene. Brain Res 1150: 182-189 (2007).
61. Kikuchi H, Furuta A, Nishioka K, Suzuki SO, Nakabeppu Y, Iwaki T. Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis. Acta Neuropathol 103: 408-414 (2002).
62. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017-3023 (2001).
63. Cash AD, Perry G, Ogawa O, Raina AK, Zhu X, Smith MA. Is Alzheimer's disease a mitochondrial disorder? Neuroscientist 8: 489-496 (2002).
64. Swerdlow RH, Kish SJ. Mitochondria in Alzheimer's disease. Int Rev Neurobiol 53: 341-385 (2002).
65. Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 101: 10726-10731 (2004).
66. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB, et al. Amyloid -induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 279: 50310-50320 (2004).
67. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 2: 324-329 (1992).
68. Selkoe DJ. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid -protein. J Alzheimers Dis 3: 75-80 (2001).
69. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 430: 631-639 (2004).
70. Reddy PH, Beal MF. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Rev 49: 618-632 (2005).
71. Reddy PH, McWeeney S. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models. Neurobiol Aging 27: 1060-1077 (2006).
72. Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120: 545-555 (2005).
73. Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem 96: 1-13 (2006).
74. Knott AB, Bossy-Wetzel E. Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration. Ann NY Acad Sci 1147: 283-292 (2008).
75. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, et al. Amyloid- overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 105: 19318-19323 (2008).
76. Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neuro- sci 7: 207-19 (2006).
77. Gu M, Cooper JM, Taanman JW, Schapira AH. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann Neurol 44: 177-186 (1998).
78. Fukae J, Mizuno Y, Hattori N. Mitochondrial dysfunction in Parkinson's disease. Mitochondrion 7: 58-62 (2007).
79. Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4(11): 600-9 (2008).
80. Alam ZI, Daniel SE, Lees AJ, Marsden DC, Jenner P, Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 69(3): 1326-9 (1997).
81. Agnati LF, Baldelli E, Andreoli N, Woods AS, Vellani V, Marcellino D, et al. On the key role played by altered protein conformation in Parkinson's disease. J Neural Transm 115(9): 1285-99 (2008).
82. Büeler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol 218: 235-246 (2009).
83. Chinta SJ, Andersen JK. Redox imbalance in Parkinson's disease. Biochim Biophys Acta 1780(11): 1362-7 (2008).
84. Surmeier DJ. Calcium, ageing, and neuronal vulnerability in Parkinson's disease. Lancet Neurol 6(10): 933-8 (2007).
85. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Roos J, Goedert M. α-synuclein in Lewy bodies. Nature 388: 839-40 (1997).
86. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. -Synuclein locus triplication causes Parkin- son's disease. Science 302(5646): 841 (2003).
87. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al. -synuclein locus duplication as a cause of fa- milial Parkinson's disease. Lancet 364: 1167-9 (2004).
88. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of -synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283: 9089-100 (2008).
89. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, et al. α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322: 1089-102 (2002).
90. Volles MJ, Lansbury PT Jr. Vesicle permeabilization by protofi- brillar -synuclein is sensitive to Parkinson's disease linked muta- tions and occurs by a pore-like mechanism. Biochem 41: 4595-602 (2002).
91. Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K. The role of -synuclein in Parkinson's disease: insights from animal models. Nat Rev Neurosci 4: 727-38 (2003).
92. Gousset K, Zurzolo C. Tunnelling nanotubes: a highway for prion spreading? Prion 3(2):1-5 (2009).
93. Parihar MS, Parihar A, Fujita M, Hashimoto M, Ghafourifar P. Mitochondrial association of -synuclein causes oxidative stress. Cell Mol Life Sci 65: 1272-1284 (2008).
94. Agnati LF, Genedani S, Leo G, Forni A, Woods AS, Filaferro M. A- peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease. J Neural Transm 114(1): 21-31(2007).
95. Baloyannis SJ. Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis 9(2): 119-26 (2006).
96. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, et al. High levels of mitochondrial DNA deletions in substan- tia nigra neurons in aging and Parkinson disease. Nat Genet 38(5): 515-7 (2006).
97. Pontes B, Viana NB, Campanati L, Farina M, Moura Neto V, Nussenzveig HM. Structure and elastic properties of tunneling nanotubes. Eur Biophys J 37: 121-129 (2008).
98. Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA 103: 1283-1288 (2006).
99. Zhu D, Tan KS, Zhang X, Sun AY, Sun GY, Lee JC. Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci 118: 3695-3703 (2005).
100. Sanders IR. Rapid disease emergence through horizontal gene transfer between eukaryotes. Trends Ecol Evol 21: 656-658 (2006).
101. Duelli D, Lazebnik Y. Cell fusion: a hidden enemy? Cancer Cell 3: 445-448 (2003).
102. Duelli D, Lazebnik Y. Cell-to-cell fusion as a link between viruses and cancer. Nat Rev Cancer 7: 968-976 (2007).
103. Vespignani A. Reaction-diffusion processes and epidemic metapopulation models in complex networks. Eur Phys J (B)64: 349-353 (2008).
104. Martín del Rey A, Hoya White S, Rodríguez Sánchez G. A model based on cellular automata to simulate epidemic diseases. Lect Notes Comput Sci 4173: 304-310 (2006).
105. Kamm RD. Cellular fluid mechanics. Annu Rev Fluid Mech 34: 211-232 (2002).
106. Bathe M, Shirai A, Doerschuk CM, Kamm RD. Neutrophil transit time through pulmonary capillaries: the effects of capillary geometry and fMLP stimulation. Biophys J 83: 1917-1933 (2002).